#1246 2003 · Sarah Cleaveland / University of Glasgow, with Tanzanian and Kenyan health authorities · Veterinary medicine / public health
Researchers cut rabies deaths by vaccinating dogs instead of treating the people they bit
the problem
Human rabies is fatal once symptoms appear, and 99 percent of exposures in rural Tanzania came from bites by rabid dogs
background
Rabies kills essentially everyone who develops symptoms, and in rural Tanzania, as across most of the developing world, 99 percent of human exposures came from a single source: bites from rabid domestic dogs. The standard response was post-exposure prophylaxis — a course of vaccine given to a bitten person before symptoms appeared — but that treatment was expensive, required a functioning cold chain and clinic access that rural villages near the Serengeti often lacked, and depended entirely on a bitten person recognizing the danger and reaching a clinic in time, which many, especially children, did not.
Scaling up post-exposure treatment meant funding a course of vaccine for every person a rabid dog might ever bite, indefinitely, in some of the hardest-to-reach clinics in Africa — treating an unlimited and unpredictable stream of victims one at a time, forever. Sarah Cleaveland and colleagues at the University of Glasgow, working with Tanzanian and Kenyan health authorities, wanted to know whether it was cheaper and more effective to close off the source of every future bite instead.
what everyone would do
Scale up post-exposure treatment access — more clinics, more vaccine stock, faster transport for bite victims — which treats every case only after a person has already been bitten and still depends on that person reaching help before symptoms appear.
what they saw
Nearly every human rabies case traced through one bottleneck — a dog bite — though the suffering was human. Vaccinating dogs closed the source for every future case at once, instead of treating victims one by one.
the move
Starting in 2003, the team ran annual mass vaccination campaigns for domestic dogs in villages around the Serengeti and Ngorongoro districts, aiming for the roughly 70 percent coverage needed to break rabies transmission through herd immunity in the dog population itself, rather than continuing to treat human bite victims one at a time after exposure.
why it works
The strategy works because it targets the transmission bottleneck rather than the symptom: with herd immunity in the dog population above roughly 70 percent, the chain of bites that would otherwise reach a human simply stops forming, so there's no exposure event left to treat. That makes cost scale with the size of the dog population once, rather than with an unpredictable and recurring stream of individual bite victims treated over and over, year after year.
the payoff
Wildlife and human rabies cases in the vaccination zone collapsed; only one wildlife case was documented inside the park after 2004.
where it breaks
It requires sustained annual coverage across a whole region, including areas with limited veterinary infrastructure, and a single lapse or reintroduction from an unvaccinated neighboring area can let the chain restart. It also only works where the disease genuinely funnels through one controllable reservoir species — for pathogens with multiple wildlife reservoirs or no equivalent choke point, vaccinating one animal population won't close off transmission the way it did here.
what came after
The Serengeti project became the proof of concept cited by WHO's global target to eliminate dog-mediated human rabies deaths by 2030, and mass dog vaccination is now the core strategy of rabies elimination programs across Africa and Asia.
references
- [1]Proof of concept of mass dog vaccination for the control and elimination of canine rabiesNational Center for Biotechnology Information (NIH) / Vaccine journal, 2019pmc.ncbi.nlm.nih.gov